How long do individual side effects last
Mechanism of Action Retatrutide simultaneously activates three metabolic receptors, distinguishing it from dual agonists such as tirzepatide (GLP-1/GIP only) and single agonists such as semaglutide (GLP-1 only)
Early-phase clinical trial data, including results from a Phase 2 trial published in The New England Journal of Medicine in 2023, demonstrated substantial weight reductions in some participants exceeding 20% of body weight over 48 weeks alongside a broadly manageable short-term adverse effect profile
Start low and increase only if tolerated
Warnings and Precautions: Thyroid C-cell tumors have occurred in animal studies
Whether these drugs need to be taken for life or whether they can be safely discontinued without losing all the benefits gained, and if so, how to best transition off are crucial issues, which still need to be fully understood.